9 research outputs found

    Voltage-Gated Sodium Channels as Potential Biomarkers and Therapeutic Targets for Epithelial Ovarian Cancer

    No full text
    Abnormal ion channel expression distinguishes several types of carcinoma. Here, we explore the relationship between voltage-gated sodium channels (VGSC) and epithelial ovarian cancer (EOC). We find that EOC cell lines express most VGSC, but at lower levels than fallopian tube secretory epithelial cells (the cells of origin for most EOC) or control fibroblasts. Among patient tumor samples, lower SCN8A expression was associated with improved overall survival (OS) (median 111 vs. 52 months; HR 2.04 95% CI: 1.21–3.44; p = 0.007), while lower SCN1B expression was associated with poorer OS (median 45 vs. 56 months; HR 0.69 95% CI 0.54–0.87; p = 0.002). VGSC blockade using either anti-epileptic drugs or local anesthetics (LA) decreased the proliferation of cancer cells. LA increased cell line sensitivity to platinum and taxane chemotherapies. While lidocaine had similar additive effects with chemotherapy among EOC cells and fibroblasts, bupivacaine showed a more pronounced impact on EOC than fibroblasts when combined with either carboplatin (ΔAUC −37% vs. −16%, p = 0.003) or paclitaxel (ΔAUC −37% vs. −22%, p = 0.02). Together, these data suggest VGSC are prognostic biomarkers in EOC and may inform new targets for therapy

    A termĂ©szetes ölƑsejtek szerepe az anyai-magzati immunhomeostasis fenntartĂĄsĂĄban

    Get PDF
    A sikeres fogantatĂĄs, beĂĄgyazĂłdĂĄs Ă©s terhessĂ©g komplex Ă©s szervezett kommunikĂĄciĂłt igĂ©nyel az embriĂł (allograft) Ă©s az anya (gazda) immunrendszere között. A kĂŒlönbözƑ leukocyta-alcsoportok fontos szerepet jĂĄtszanak az immunvĂĄlasz szervezĂ©sĂ©ben a magzati-anyai hatĂĄrfelĂŒleten. Vannak bizonyos hasonlĂłsĂĄgok a tumorsejteknek az immunrendszert kijĂĄtszĂł kĂłros Ă©s az embrionĂĄlis eredetƱ trophoblastsejteknek az anyai deciduĂĄba irĂĄnyulĂł fiziolĂłgiĂĄs invĂĄziĂłja között. A decidualis vagy uterinalis termĂ©szetes ölƑsejtek a termĂ©szetes ölƑsejtek speciĂĄlis rĂ©szhalmaza, Ă©s a macrophagokkal Ă©s a dendritikus sejtekkel egyĂŒtt a veleszĂŒletett immunrendszer rĂ©szĂ©t kĂ©pezik, ezĂ©rt Ƒk az elsƑ immunsejtek, amelyek kapcsolatba lĂ©pnek bĂĄrmely behatolĂłval, legyen az daganat vagy embrionĂĄlis szövet. Érdekes mĂłdon a decidualis termĂ©szetes ölƑsejtek nemcsak nem tĂĄmadjĂĄk meg az invazĂ­v trophoblastsejteket, hanem kifejezetten elƑsegĂ­tik azok progressziĂłjĂĄt. Angiogenikus aktivitĂĄsuk megkönnyĂ­ti Ă©s koordinĂĄlja a kialakulĂł mĂ©hlepĂ©ny helyi vascularis ĂĄtalakulĂĄsĂĄt. Dolgozatunkban ĂĄttekintjĂŒk a trophoblastsejtek Ă©s a decidualis termĂ©szetes ölƑsejtek kölcsönhatĂĄsait, a decidualis termĂ©szetes ölƑsejtek szerepĂ©t a decidua vascularisatiĂłjĂĄban Ă©s immunhĂĄztartĂĄsĂĄban

    Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube

    No full text
    Abstract Background Ovarian cancer is the leading cause of death among gynecologic diseases in Western countries. We have previously identified a miR-200-E-cadherin axis that plays an important role in ovarian inclusion cyst formation and tumor invasion. The purpose of this study was to determine if the miR-200 pathway is involved in the early stages of ovarian cancer pathogenesis by studying the expression levels of the pathway components in a panel of clinical ovarian tissues, and fallopian tube tissues harboring serous tubal intraepithelial carcinomas (STICs), a suggested precursor lesion for high-grade serous tumors. Methods RNA prepared from ovarian and fallopian tube epithelial and stromal fibroblasts was subjected to quantitative real-time reverse-transcription polymerase chain reaction (qRT-PCR) to determine the expression of miR-200 families, target and effector genes and analyzed for clinical association. The effects of exogenous miR-200 on marker expression in normal cells were determined by qRT-PCR and fluorescence imaging after transfection of miR-200 precursors. Results Ovarian epithelial tumor cells showed concurrent up-regulation of miR-200, down-regulation of the four target genes (ZEB1, ZEB2, TGFÎČ1 and TGFÎČ2), and up-regulation of effector genes that were negatively regulated by the target genes. STIC tumor cells showed a similar trend of expression patterns, although the effects did not reach significance because of small sample sizes. Transfection of synthetic miR-200 precursors into normal ovarian surface epithelial (OSE) and fallopian tube epithelial (FTE) cells confirmed reduced expression of the target genes and elevated levels of the effector genes CDH1, CRB3 and EpCAM in both normal OSE and FTE cells. However, only FTE cells had a specific induction of CA125 after miR-200 precursor transfection. Conclusions The activation of the miR-200 pathway may be an early event that renders the OSE and FTE cells more susceptible to oncogenic mutations and histologic differentiation. As high-grade serous ovarian carcinomas (HGSOC) usually express high levels of CA125, the induction of CA125 expression in FTE cells by miR-200 precursor transfection is consistent with the notion that HGSOC has an origin in the distal fallopian tube

    Additional file 1: of Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube

    No full text
    Fig. S1. Western blot analysis to show negligible expression of CA125 (MUC16) in OSE and FTE primary cultures. Table S1. Correlation analyses for the relationship between expression levels of miR-200 family and miR-205 and target genes. Table S2. Correlation analyses for the expression relationship between miR-200 family and miR-205 and effector genes. Table S3. Differential expression of effector gene MUC16 in different subtypes of ovarian tumors. Table S4. Effects of microRNA on target gene expression in OSE and FTE cells. Table S5. Effects of microRNA on effector gene expression in OSE and FTE (PDF 445 kb

    Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    No full text
    non present

    Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    No full text
    corecore